Today: 17 June 2026

Cemtrex (CETX) stock ends lower as FY2025 results tout operating profit but 10-K flags going-concern doubt

Cemtrex (CETX) stock ends lower as FY2025 results tout operating profit but 10-K flags going-concern doubt

Cemtrex shares fell 7.5% to $2.11 Monday before the company reported fiscal 2025 revenue rose to $76.5 million and a return to operating profit. Its annual filing showed a net loss of $28.3 million, driven by $26 million in warrant-related charges, and flagged “substantial doubt” about the company’s ability to continue as a going concern due to near-term funding needs and $13.5 million in debt.
ConocoPhillips stock closes higher as oil jumps; inventories and Feb. 5 earnings date in focus

ConocoPhillips stock closes higher as oil jumps; inventories and Feb. 5 earnings date in focus

ConocoPhillips shares rose 1.2% to $92.63 on Monday as crude oil settled more than 2% higher, following reports of rising U.S. inventories and renewed geopolitical tensions. The stock traded between $91.70 and $92.72 on volume of 5.3 million shares. U.S. crude inventories increased by 405,000 barrels last week, while gasoline stocks climbed 2.86 million barrels, according to the EIA.
BNAI stock doubles as Brand Engagement Network lands AI pharma deal, eyes recurring fees

BNAI stock doubles as Brand Engagement Network lands AI pharma deal, eyes recurring fees

Brand Engagement Network shares surged 108.8% to $2.51 Monday after announcing a pharma AI contract expected to bring $250,000 in Q4 revenue and monthly license fees in early 2026. Volume jumped to 148.6 million shares. The company reported $102,715 in cash at Sept. 30 and $60,120 in Q3 revenue. Traders are watching if BNAI holds above $2.50 after the spike.
Parker-Hannifin stock today: PH ends higher as Wall Street wobbles into year-end

Parker-Hannifin stock today: PH ends higher as Wall Street wobbles into year-end

Parker-Hannifin shares rose 0.3% to $890.55 Monday, bucking a broader market decline as tech stocks fell. About 440,000 shares traded in a session marked by light news and thin year-end volume. Investors focused on Parker’s pending $9.25 billion Filtration Group deal, which is expected to close within a year. The company last raised its fiscal 2026 outlook after posting record sales in November.
30 December 2025
Southern Copper stock drops late Monday as metals selloff hits miners; what’s next for SCCO

Southern Copper stock drops late Monday as metals selloff hits miners; what’s next for SCCO

Southern Copper Corp fell 2.8% to $145.30 late Monday, tracking a sharp selloff in metals after CME Group raised margin requirements. Spot gold dropped 4.5%, silver 9.5%, and copper 4.8%, pressuring mining stocks. About 1.1 million SCCO shares traded between $143.75 and $149.00. Investors await Fed minutes Tuesday and Southern Copper’s earnings in February.
Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

Novo Nordisk is cutting Wegovy prices in China, with local reports citing 48% reductions for the highest doses in Yunnan and Sichuan. The move comes as the company faces a 2026 patent expiry for semaglutide and rising competition from Chinese drugmakers. Novo shares fell after the China pricing news circulated. The company did not disclose exact new prices in its statement.
30 December 2025
Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices stock slips into year-end as chip shares cool; Fed minutes and ADI earnings on deck

Analog Devices Inc shares fell 0.44% to $275.63 Monday, marking a second straight decline. The Philadelphia Semiconductor Index dropped 31.94 points to 7,178.27 as chip stocks tracked a weaker U.S. market. Investors await Federal Reserve minutes Tuesday after policymakers cut rates but signaled caution. Analog Devices last issued upbeat guidance in late November, projecting fiscal Q1 revenue above analyst estimates.
Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

Gilead Sciences shares closed up 0.15% at $124.91 on Monday after Bernstein said new Medicaid drug-pricing rules would have limited impact on its HIV drug Biktarvy. Bernstein estimated less than $200 million in 2026 revenue impact for older HIV drugs Genvoya and Odefsey. Investors await more details from the Trump administration’s pricing rollout and Gilead’s update at the J.P. Morgan Healthcare Conference in January.
30 December 2025

Stock Market Today

  • ERock Simplifies Equity Structure and Adds Independent Board After IPO
    June 16, 2026, 9:15 PM EDT. ERock (NYSE:EROC) completed its IPO, raising capital to support its power systems business. The company simplified its equity structure through repurchases and restructuring, adopting new bylaws and a revised certificate of incorporation. It established a new independent board with defined committee roles, aiming to strengthen governance. ERock trades at $15.30 with no analyst price targets yet and is flagged as undervalued by one estimate, trading nearly 96% below fair value. Investors should monitor how the board manages IPO proceeds against current revenue of $190.8 million and a net loss of $68.2 million. Shares are highly illiquid, possibly causing wider spreads and price volatility. These changes offer a clearer foundation for public oversight as ERock transitions to a public company.

Latest articles

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

17 June 2026
Dow hits second straight record close at 51,999.67 while S&P 500 and Nasdaq drop as tech stocks slide; Philadelphia semiconductor index plunges 5.7% and after-hours trading sees only slight gains for major index-tracking funds, as investors brace for Wednesday’s Fed decision and monitor inflation risks amid falling oil prices and a possible U.S.-Iran deal.
GD Culture shares drop on heavy trading and ongoing buyout uncertainty

GD Culture shares drop on heavy trading and ongoing buyout uncertainty

17 June 2026
GD Culture Group plunged 73.3% to $0.028 after heavy trading, putting fresh pressure on its unresolved, non-binding $10.75-per-share buyout proposal; risks include deal uncertainty, a $300 million share-sale program, and bitcoin-driven balance sheet swings, with no new company updates released Tuesday.
Go toTop